MDMA-assisted therapy for PTSD is in the final stages of FDA testing. Clinical trials are reporting a 70 percent cure rate for a condition that claims thousands of lives globally every day—hundreds in the US alone.But until it’s fully legalized, MDMA is still a Schedule I drug, saddled with years of misunderstanding, misinformation, and misuse.In this groundbreaking, informative, and easy-to-read book, Dr. Dan Engle shows you the treatment through the eyes of a fictional pati...